IRIS Accounts Production v25.1.0.734 10502189 Board of Directors 1.12.23 30.11.24 30.11.24 0 0 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh105021892023-11-30105021892024-11-30105021892023-12-012024-11-30105021892022-11-30105021892022-12-012023-11-30105021892023-11-3010502189ns15:EnglandWales2023-12-012024-11-3010502189ns14:PoundSterling2023-12-012024-11-3010502189ns10:Director12023-12-012024-11-3010502189ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3010502189ns10:SmallEntities2023-12-012024-11-3010502189ns10:AuditExemptWithAccountantsReport2023-12-012024-11-3010502189ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3010502189ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3010502189ns10:FullAccounts2023-12-012024-11-301050218912023-12-012024-11-3010502189ns10:OrdinaryShareClass12023-12-012024-11-3010502189ns10:Director22023-12-012024-11-3010502189ns10:CompanySecretary12023-12-012024-11-3010502189ns10:RegisteredOffice2023-12-012024-11-3010502189ns5:CurrentFinancialInstruments2024-11-3010502189ns5:CurrentFinancialInstruments2023-11-3010502189ns5:Non-currentFinancialInstruments2024-11-3010502189ns5:Non-currentFinancialInstruments2023-11-3010502189ns5:ShareCapital2024-11-3010502189ns5:ShareCapital2023-11-3010502189ns5:RetainedEarningsAccumulatedLosses2024-11-3010502189ns5:RetainedEarningsAccumulatedLosses2023-11-3010502189ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3010502189ns5:ComputerSoftware2023-12-012024-11-3010502189ns5:OwnedAssets2023-12-012024-11-3010502189ns5:OwnedAssets2022-12-012023-11-3010502189ns5:IntangibleAssetsOtherThanGoodwill2023-11-3010502189ns5:IntangibleAssetsOtherThanGoodwill2024-11-3010502189ns5:IntangibleAssetsOtherThanGoodwill2023-11-3010502189ns5:PlantMachinery2023-11-3010502189ns5:PlantMachinery2023-12-012024-11-3010502189ns5:PlantMachinery2024-11-3010502189ns5:PlantMachinery2023-11-3010502189ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3010502189ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3010502189ns10:OrdinaryShareClass12024-11-3010502189ns5:RetainedEarningsAccumulatedLosses2023-11-3010502189ns5:RetainedEarningsAccumulatedLosses2023-12-012024-11-30
REGISTERED NUMBER: 10502189 (England and Wales)















Report of the Directors and

Financial Statements for the Year Ended 30 November 2024

for

Retina Macula Uk Limited

Retina Macula Uk Limited (Registered number: 10502189)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Report of the Directors 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 6


Retina Macula Uk Limited

Company Information
for the Year Ended 30 November 2024







DIRECTORS: Dr T Empeslidis
Mrs P Empeslidis





SECRETARY:





REGISTERED OFFICE: 65a High Street
Stevenage
Hertfordshire
SG1 3AQ





REGISTERED NUMBER: 10502189 (England and Wales)





ACCOUNTANTS: Long & Co (Dentax) Ltd
65a High Street
Stevenage
Hertfordshire
SG1 3AQ

Retina Macula Uk Limited (Registered number: 10502189)

Report of the Directors
for the Year Ended 30 November 2024

The directors present their report with the financial statements of the company for the year ended 30 November 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of scientific and technical activities.

DIRECTORS
The directors set out in the table below have held office during the whole of the period from 1 December 2023 to the date of this report.

The beneficial interests of the directors holding office at 30 November 2024 in the shares of the company, according to the register of directors' interests, were as follows:

30.11.24 1.12.23
Ordinary shares of £1 each
Dr T Empeslidis - -
Mrs P Empeslidis 10 10

These directors did not hold any non-beneficial interests in the shares of the company.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Dr T Empeslidis - Director


13 May 2025

Retina Macula Uk Limited (Registered number: 10502189)

Income Statement
for the Year Ended 30 November 2024

2024 2023
Notes £    £   

TURNOVER 187,310 379,772

Cost of sales (31,152 ) (43,788 )
GROSS PROFIT 156,158 335,984

Administrative expenses (100,560 ) (194,973 )
OPERATING PROFIT 4 55,598 141,011


Interest payable and similar expenses (6,773 ) (640 )
PROFIT BEFORE TAXATION 48,825 140,371

Tax on profit (6,656 ) (30,882 )
PROFIT FOR THE FINANCIAL YEAR 42,169 109,489

Retina Macula Uk Limited (Registered number: 10502189)

Balance Sheet
30 November 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 5 - -
Tangible assets 6 112,978 3,839
112,978 3,839

CURRENT ASSETS
Debtors 7 61,409 148,184
Cash at bank 48,943 123,761
110,352 271,945
CREDITORS
Amounts falling due within one year 8 (14,060 ) (37,949 )
NET CURRENT ASSETS 96,292 233,996
TOTAL ASSETS LESS CURRENT
LIABILITIES

209,270

237,835

CREDITORS
Amounts falling due after more than one
year

9

(6,438

)

(7,572

)
NET ASSETS 202,832 230,263

CAPITAL AND RESERVES
Called up share capital 10 10 10
Retained earnings 11 202,822 230,253
SHAREHOLDERS' FUNDS 202,832 230,263

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Retina Macula Uk Limited (Registered number: 10502189)

Balance Sheet - continued
30 November 2024


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 13 May 2025 and were signed on its behalf by:





Dr T Empeslidis - Director


Retina Macula Uk Limited (Registered number: 10502189)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

Retina Macula Uk Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

Retina Macula Uk Limited (Registered number: 10502189)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

4. OPERATING PROFIT

The operating profit is stated after charging:

2024 2023
£    £   
Depreciation - owned assets 6,755 1,279

5. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 December 2023
and 30 November 2024 9,240
AMORTISATION
At 1 December 2023
and 30 November 2024 9,240
NET BOOK VALUE
At 30 November 2024 -
At 30 November 2023 -

6. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2023 6,988
Additions 115,894
At 30 November 2024 122,882
DEPRECIATION
At 1 December 2023 3,149
Charge for year 6,755
At 30 November 2024 9,904
NET BOOK VALUE
At 30 November 2024 112,978
At 30 November 2023 3,839

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed by group undertakings 53,051 39,599
Other debtors 8,358 108,585
61,409 148,184

Retina Macula Uk Limited (Registered number: 10502189)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 5,231 4,929
Taxation and social security 6,656 30,882
Other creditors 2,173 2,138
14,060 37,949

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 6,438 7,572

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
10 Ordinary £1 10 10

11. RESERVES
Retained
earnings
£   

At 1 December 2023 230,253
Profit for the year 42,169
Dividends (69,600 )
At 30 November 2024 202,822